Memantine and Down's Syndrome

NCT00240760 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Down's Syndrome
Dementia
Learning Disabilities

Interventions

DRUG: Memantine Hydrochloride

Sponsor

King's College London